Pandemic telehealth flexibilities for buprenorphine treatment: a synthesis of evidence and policy implications for expanding opioid use disorder care in the United States.

导出 LinkOut

翻译打印收藏纠错

作者： Noa,Krawczyk ^[1] ; Bianca D,Rivera ^[1] ; Carla,King ^[1] ; Bridget C E,Dooling ^[2]

作者单位： Center for Opioid Epidemiology and Policy (COEP), Department of Population Health, NYU Grossman School of Medicine, 180 Madison, New York, NY 10016, United States. ^[1] Regulatory Studies Center, The George Washington University, Washington, DC 20052, United States. ^[2]

关键词 COVID-19 buprenorphine federal regulations opioid use disorder overdose pandemic policy translation telehealth telemedicine treatment

DOI 10.1093/haschl/qxad013

PMID 38145115

发布时间 2024-01-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Health affairs scholar

2023年1卷1期

qxad013页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Pandemic telehealth flexibilities for buprenorphine treatment: a synthesis of evidence and policy implications for expanding opioid use disorder care in the United States.

Health affairs scholar

相似文献

Health affairs scholar

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Pandemic telehealth flexibilities for buprenorphine treatment: a synthesis of evidence and policy implications for expanding opioid use disorder care in the United States.

Health affairs scholar

相似文献

Health affairs scholar

相关期刊

检索历史清除